Our finding suggested that a dual‐targeted nanosystem combined with R848, MIP‐3α, and DOX containing an equivalent dose of R848 (1 mg/kg) injected four times in 4T1 tumor‐bearing mice suppress tumor volume below 100 mm3. The gene discussed is CCL20; the disease is neoplasm.